Edward J. Rapp
CIK: 0001171780
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 10, 2026XOS
Xos, Inc.
Award(A)Direct1.8K shares- - Sep 30, 2026ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
129 shares at avg. $261.59- - Jul 10, 2026XOS
Xos, Inc.
Award(A)Direct2.7K shares- - Jul 10, 2026XOS
Xos, Inc.
Award(A)Direct60.6K shares- - Jun 30, 2026ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
134 shares at avg. $251.64- - May 8, 2026ABBV
AbbVie Inc.
Award(A)Direct1.1K shares- - Apr 10, 2026XOS
Xos, Inc.
Award(A)Direct5.2K shares- - Mar 31, 2026ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
155 shares at avg. $217.49- - Jan 10, 2026XOS
Xos, Inc.
Award(A)Direct2.4K shares- - Dec 31, 2025ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
147 shares at avg. $228.49- - Oct 10, 2025XOS
Xos, Inc.
Award(A)Direct1.9K shares- - Sep 30, 2025ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
145 shares at avg. $231.54- - Jul 10, 2025XOS
Xos, Inc.
Award(A)Direct62.4K shares- - Jul 10, 2025XOS
Xos, Inc.
Award(A)Direct1.6K shares- - Jun 30, 2025ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
177 shares at avg. $185.62- - May 9, 2025ABBV
AbbVie Inc.
Award(A)Direct1.2K shares- - Apr 10, 2025XOS
Xos, Inc.
Award(A)Direct1.4K shares- - Mar 31, 2025ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
155 shares at avg. $209.52- - Jan 10, 2025XOS
Xos, Inc.
Award(A)Direct1.5K shares- - Jan 10, 2025XOS
Xos, Inc.
Award(A)Direct1.1K shares- - Dec 31, 2024ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
182 shares at avg. $177.70- - Oct 10, 2024XOS
Xos, Inc.
Award(A)Direct1.1K shares- - Sep 30, 2024ABBV
AbbVie Inc.
Award(A)DirectStock Equivalent Units
164 shares at avg. $197.48-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 10, 2026 | XOS Xos, Inc. | Award(A) | 1,814 | - | $0 | Direct |
| Sep 30, 2026 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 129 | $261.59 | - | Direct |
| Jul 10, 2026 | XOS Xos, Inc. | Award(A) | 2,670 | - | $0 | Direct |
| Jul 10, 2026 | XOS Xos, Inc. | Award(A) | 60,584 | - | $0 | Direct |
| Jun 30, 2026 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 134 | $251.64 | - | Direct |
| May 8, 2026 | ABBV AbbVie Inc. | Award(A) | 1,118 | - | $0 | Direct |
| Apr 10, 2026 | XOS Xos, Inc. | Award(A) | 5,182 | - | $0 | Direct |
| Mar 31, 2026 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 155 | $217.49 | - | Direct |
| Jan 10, 2026 | XOS Xos, Inc. | Award(A) | 2,401 | - | $0 | Direct |
| Dec 31, 2025 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 147 | $228.49 | - | Direct |
| Oct 10, 2025 | XOS Xos, Inc. | Award(A) | 1,883 | - | - | Direct |
| Sep 30, 2025 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 145 | $231.54 | - | Direct |
| Jul 10, 2025 | XOS Xos, Inc. | Award(A) | 62,377 | - | - | Direct |
| Jul 10, 2025 | XOS Xos, Inc. | Award(A) | 1,601 | - | - | Direct |
| Jun 30, 2025 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 177 | $185.62 | - | Direct |
| May 9, 2025 | ABBV AbbVie Inc. | Award(A) | 1,203 | - | - | Direct |
| Apr 10, 2025 | XOS Xos, Inc. | Award(A) | 1,407 | - | - | Direct |
| Mar 31, 2025 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 155 | $209.52 | - | Direct |
| Jan 10, 2025 | XOS Xos, Inc. | Award(A) | 1,475 | - | - | Direct |
| Jan 10, 2025 | XOS Xos, Inc. | Award(A) | 1,065 | - | $0 | Direct |
| Dec 31, 2024 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 182 | $177.70 | - | Direct |
| Oct 10, 2024 | XOS Xos, Inc. | Award(A) | 1,065 | - | $0 | Direct |
| Sep 30, 2024 | ABBV AbbVie Inc. | Award(A) Stock Equivalent Units | 164 | $197.48 | - | Direct |
1-23 of 23 transactions
About RAPP EDWARD J
RAPP EDWARD J (SEC CIK 0001171780) files insider reports with the SEC as Director of Xos, Inc. (XOS) and Director of AbbVie Inc. (ABBV).
Signal8 holds 21 ownership filings by RAPP EDWARD J, all Form 4s, filed between Oct 2, 2024 and Oct 13, 2026. Those filings report 23 transactions, from Sep 30, 2024 to Oct 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RAPP EDWARD J's filings is in NORTH CHICAGO, IL.
Recent filings by RAPP EDWARD J
- Oct 10, 2026: Grant or award of XOS shares (Form 4, code A).
- Sep 30, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
- Jul 10, 2026: Grants or awards of XOS shares (2 lines, Form 4, code A).
- Jun 30, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
- May 8, 2026: Grant or award of ABBV shares (Form 4, code A).
Other insiders filing for Xos, Inc. (XOS)
- Pogosyan Liana, Chief Financial Officer
- Sordoni Giordano, Chief Operating Officer
- Semler Dakota, Chief Executive Officer
- Mattson George N, Director
- OSTERMANN DIETMAR, Director
- Yake Alice, Director